Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of The Diagnostic Value of Two Cell-based Assays for MOG-IgG-associated Diseases: A Multicenter, Paired Design Observational Study

NCT06617962 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT06617962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06617962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of The Diagnostic Value of Two Cell-based Assays for MOG-IgG-associated Diseases: A Multicenter, Paired Design Observational Study
Lead sponsor
Huashan Hospital
Phase
Observational
Overall status
Recruiting
Start date
November 18, 2024
Completion date
December 31, 2026
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myelin oligodendrocyte glycoprotein (mog)-antibody related disorders